We feel now is a pretty good time to analyse Aurora Cannabis Inc.’s (TSE:ACB) business as it appears the company may be on the cusp of a considerable accomplishment. Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. With the latest financial year loss of CA$1.7b and a trailing-twelve-month loss of CA$818m, the CA$337m market-cap company alleviated its loss by moving closer towards its target of breakeven. The most pressing concern for investors is Aurora Cannabis’ path to profitability – when will it breakeven? In this article, we will touch on the expectations for the company’s growth and when analysts expect it to become profitable.
Check out our latest analysis for Aurora Cannabis
Aurora Cannabis is bordering on breakeven, according to the 10 Canadian Pharmaceuticals analysts. They anticipate the company…
